Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-26

FDA Approved: CLOBETASOL PROPIONATE — Original Application (AvKARE)

View source ↗

Summary

FDA approved AvKARE's original ANDA for clobetasol propionate topical product (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

ORIG AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)